Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy

Daniel P. Judge, Kevin M. Alexander, Francesco Cappelli, Marianna Fontana, Pablo Garcia-Pavia, Simon D.J. Gibbs, Martha Grogan, Mazen Hanna, Ahmad Masri, Mathew S. Maurer, Laura Obici, Prem Soman, Xiaofan Cao, Ted Lystig, Jean-François Tamby, Suresh Siddhanti, Adam Castaño, Leonid Katz, Jonathan C. Fox, Kenneth W. Mahaffey, Julian D. Gillmore

Open source

DOI: 10.1016/j.jacc.2024.11.042
Published: 2025-03
Container: Journal of the American College of Cardiology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jacc.2024.11.042,
  title = {Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy},
  author = {Daniel P. Judge and Kevin M. Alexander and Francesco Cappelli and Marianna Fontana and Pablo Garcia-Pavia and Simon D.J. Gibbs and Martha Grogan and Mazen Hanna and Ahmad Masri and Mathew S. Maurer and Laura Obici and Prem Soman and Xiaofan Cao and Ted Lystig and Jean-François Tamby and Suresh Siddhanti and Adam Castaño and Leonid Katz and Jonathan C. Fox and Kenneth W. Mahaffey and Julian D. Gillmore},
  year = {2025},
  journal = {Journal of the American College of Cardiology},
  doi = {10.1016/j.jacc.2024.11.042},
  url = {https://doi.org/10.1016/j.jacc.2024.11.042}
}

RIS

TY  - JOUR
TI  - Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy
AU  - Daniel P. Judge
AU  - Kevin M. Alexander
AU  - Francesco Cappelli
AU  - Marianna Fontana
AU  - Pablo Garcia-Pavia
AU  - Simon D.J. Gibbs
AU  - Martha Grogan
AU  - Mazen Hanna
AU  - Ahmad Masri
AU  - Mathew S. Maurer
AU  - Laura Obici
AU  - Prem Soman
AU  - Xiaofan Cao
AU  - Ted Lystig
AU  - Jean-François Tamby
AU  - Suresh Siddhanti
AU  - Adam Castaño
AU  - Leonid Katz
AU  - Jonathan C. Fox
AU  - Kenneth W. Mahaffey
AU  - Julian D. Gillmore
PY  - 2025
JO  - Journal of the American College of Cardiology
DO  - 10.1016/j.jacc.2024.11.042
UR  - https://doi.org/10.1016/j.jacc.2024.11.042
ER  -

APA

Judge, D. P., Alexander, K. M., Cappelli, F., Fontana, M., Garcia-Pavia, P., Gibbs, S. D., Grogan, M., Hanna, M., Masri, A., Maurer, M. S., Obici, L., Soman, P., Cao, X., Lystig, T., Tamby, J., Siddhanti, S., Castaño, A., Katz, L., Fox, J. C., Mahaffey, K. W., & Gillmore, J. D. (2025). Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2024.11.042

Source records

crossref · retrieved 2026-09-26T06:07:56.741Z